This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

EsoCap AG



Currently there is no single medication that can be administered locally in the esophagus. EsoCap develops a smart application technology allowing a targeted drug delivery in the esophagus with prolonged mucosal contact time and controlled release of APIs. The EsoCap technology addresses a major need expressed by international KOLs. Our business model is to show clinical feasibility in one indication and to seek a partner.

Presenter: Isabelle Racamier, CEO, EsoCap AG